Organon to Present New Research on Access and Value at ISPOR 2026
Organon will present eight accepted abstracts at ISPOR 2026, the leading global conference for health economics and outcomes research. The presentations cover real-world evidence and budget impact analyses for key assets including NEXPLANON, VTAMA, POHERDY, and HADLIMA.
Key figures
- Abstract count
- 8
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.